Date Title
14 Aug 2015 RCE Patient Advocates course: meeting resources
01 Aug 2015 ESMO E-Learning: Multidisciplinary Treatment for Glioblastoma
26 Jun 2015 RCE Patient Advocates course on the Methodology of clinical studies in rare cancers
22 Jun 2015 Updated MAC-NPC meta-analysis: concomitant chemotherapy to radiotherapy improves survival in locoregionally advanced nasopharyngeal carcinoma
04 Jun 2015 Press Release: Workshop on chordoma discusses challenges of drug development for rare cancers
04 Jun 2015 ASCO 2015: Phase III Randomised Trial Shows Superiority of Lenalidomide/Dexamethasone With Elotuzumab for Relapsed/Refractory Multiple Myeloma
30 Apr 2015 EMA/ESMO/Rare Cancers Europe: Joint workshop on chordoma as a model for very rare cancers
01 Apr 2015 Translational Study Identifies BRAF V600E Mutation And CDKN2A Deletion As Markers For Malignant Transformation In Low-Grade Paediatric Gliomas
24 Mar 2015 Press Release: Urgent Need For European Reference Networks For Rare Cancers
23 Mar 2015 Discussion On The Quality Of Care For Rare Cancers In Belgium
18 Mar 2015 Phase III trial shows positive results for bortezomib-based first-line treatment in mantle-cell lymphoma
10 Mar 2015 Press release: Rare Cancers Europe: Improving The Organisation Of Healthcare For Rare Cancer Patients
25 Feb 2015 Press Release: Rare Disease Day 2015 - Living With A Rare Cancer
24 Feb 2015 Interview with RCE Chair Paolo Casali in Innovations in Oncology Report
18 Feb 2015 FDA Approves Lenvatinib for Differentiated Thyroid Cancer Refractory to Iodine-131